Mytide Therapeutics

Boston, United States

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

Mar 2022

Series A

Top Investors

Alloy TherapeuticsNational Science FoundationCreative Destruction LabMassachusetts Life Sciences CenterUncommon Denominator

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mytide Therapeutics

Who are Mytide Therapeutics's investors?

Mytide Therapeutics's investors include Alloy Therapeutics, National Science Foundation, Creative Destruction Lab, Massachusetts Life Sciences Center, Uncommon Denominator.

Where is Mytide Therapeutics headquartered?

Mytide Therapeutics is headquartered in Boston, United States.

What does Mytide Therapeutics do?

Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.

What stage is Mytide Therapeutics at?

Mytide Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 8, 2022.

MLA

"Mytide Therapeutics — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/mytide-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Mytide Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/mytide-therapeutics

Wikipedia (cite web)

{{cite web |title=Mytide Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mytide-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 8, 2022.